BuXiang Pharmaceuticals: Net profit attributable to the parent company in the first half of the year was 628 million yuan, a year-on-year increase of 171.24%.

The semi-annual report disclosed by Bausch Health on August 27th showed that the company achieved operating income of 5.664 billion yuan in the first half of the year, a year-on-year increase of 4.27%; net profit attributable to shareholders of the listed company was 628 million yuan, a year-on-year increase of 171.24%; and basic earnings per share were 0.5934 yuan.